Lorundrostat cut systolic BP by 9.6 mm Hg and UACR by 52.2% vs placebo in participants with CKD and uncontrolled hypertension in Launch-HTN.
|Articles|June 3, 2022
Case Report: Slow AFib?
Author(s)Brady Pregerson, MD
Our latest case report from Brady Pregerson, MD, features an elderly male with a past medical history of diabetes and stage 5 CKD presenting with 2 days of nausea, vomiting, and generalized weakness. Check out the EKG and determine the correct diagnosis!
Advertisement
History:
An elderly male with a past medical history of diabetes and stage 5 chronic kidney disease is brought to the hospital by medics with 2 days of nausea, vomiting and generalized weakness. He denies any chest pain, difficulty breathing, fever, chills, abdominal pain, diarrhea, melena, or other complaints. He has a dialysis fistula but has not yet started dialysis. His home medications include losartan, amlodipine, Lasix, sitagliptin, and Plavix.
Exam:
He is normotensive however heart rate is in the 20–30s range. His extremities are warm and well perfused with a palpable thrill in the left arm. He is not confused. He has faint crackles in the bases bilaterally with trace lower extremity edema.
What is the rhythm?
Advertisement
Related to this article
The ENRICH-AF trial ultimately did not demonstrate edoxaban’s efficacy, highlighting the need for further stroke prevention strategies for this patient population.
A recent MRI analysis of the pivotal OCEANIC-STROKE trial has indicated a complete lack of association between infarct patterns and asundexian’s efficacy.
A new analysis of 4 major trials has revealed the association between lower SBP and higher TTR and the risk of recurrent stroke after intracerebral hemorrhage.
Data from the phase 2a BIRCH trial demonstrated the treatment’s improvements in mRS and NLR, positioning it for a late-phase trial in the future.
A new analysis of the BRIDGE-TNK trial has demonstrated that patients with cardioembolism are more likely to derive benefit than those with large artery atherosclerosis.
Advertisement
Advertisement
Trending on HCPLive
1
eGFR Underestimates CKD in Patients with Cancer, Study Finds
2
The HCPFive: Top News for Healthcare Providers from the Week of 10/18
3
42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER
4
Q&A: Looking Beyond Body Surface Area in Atopic Dermatitis Treatment Selection
5